Ipratropium for Pertussis Cough
Ipratropium bromide is NOT effective for treating the characteristic paroxysmal cough of pertussis (whooping cough) and should not be used for this indication. 1
Evidence Against Ipratropium for Pertussis
The most definitive evidence comes from a Cochrane systematic review that specifically evaluated symptomatic treatments for whooping cough, including salbutamol (a beta-2 agonist similar in mechanism to ipratropium's bronchodilator effects). This review found no statistically significant benefit for any intervention aimed at suppressing the paroxysmal cough in pertussis. 1
- Salbutamol showed no change in coughing paroxysms per 24 hours (mean difference -0.22,95% CI -4.13 to 3.69) 1
- The review concluded that insufficient evidence exists to support any intervention for the cough in whooping cough 1
- Nine studies were analyzed, though all were small and performed in industrialized settings 1
Why Ipratropium Works for Other Post-Infectious Coughs But NOT Pertussis
Post-Infectious Cough (Non-Pertussis)
For typical post-infectious cough following upper respiratory infections, ipratropium bromide IS recommended as first-line therapy with fair quality evidence (Grade B). 2, 3
- A controlled trial demonstrated that inhaled ipratropium (320 mcg/day) significantly reduced day and night-time cough in non-smoking adults with protracted post-viral cough 4
- The ACCP guidelines specifically recommend considering ipratropium for post-infectious cough as it may attenuate symptoms 2, 5
- Twelve of 14 patients showed overall clinical improvement, with five achieving complete resolution 4
The Critical Distinction: Pertussis is Different
The ACCP guidelines explicitly state that their recommendations for ipratropium apply to "postinfectious cough, not due to bacterial sinusitis or early on in a Bordetella pertussis infection." 2
- Pertussis causes a uniquely virulent form of post-infectious cough with distinct pathophysiology 2
- The characteristic paroxysmal cough, post-tussive vomiting, and inspiratory whooping sound indicate a different mechanism than typical post-viral cough 2
- Pertussis toxin and other virulence factors cause specific airway damage that does not respond to anticholinergic bronchodilation 2
What DOES Work for Pertussis
Early-Stage Treatment (First 1-2 Weeks)
Macrolide antibiotics are the only evidence-based treatment for pertussis, but ONLY when administered early in the disease course. 2
- Antibiotics reduce transmission and should be started as soon as pertussis is suspected 2
- Patients should be isolated for 5 days from the start of antibiotic treatment 5
- After the paroxysmal stage begins, antibiotics do not reduce cough severity or duration 2
Symptomatic Management
No intervention has proven effective for the established paroxysmal cough of pertussis. 1
- Corticosteroids showed no clear benefit (mean reduction in hospital stay -3.5 days, 95% CI -15.3 to 8.4) 1
- Pertussis immunoglobulin showed no significant change in hospital stay or whooping episodes 1
- Diphenhydramine did not reduce coughing spells 1
Clinical Algorithm
When Cough Presents After URI:
If cough has typical post-viral features (no paroxysms, no post-tussive vomiting, no whooping):
If cough lasts ≥2 weeks with paroxysms, post-tussive vomiting, or inspiratory whooping:
If pertussis is confirmed but paroxysmal stage is established:
Common Pitfalls to Avoid
- Do not assume all post-infectious coughs are the same - pertussis requires specific recognition and different management 2
- Do not delay antibiotic treatment if pertussis is suspected early in the illness, as this is the only window for effective intervention 2
- Do not waste resources on symptomatic treatments for established pertussis cough, as none have proven effective 1
- Do not forget isolation precautions - pertussis is highly contagious in both children and adults 2